All filters
Slidesets
Reaching 90-90-90 and beyond- Kees Brinkman, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Reaching 90-90-90 and beyond- Kees Brinkman, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Eradication of HIV- Bonaventura Clotet, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Eradication of HIV- Bonaventura Clotet, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Living donor liver transplantation for hepatitis virus related liver diseases- Chao-Long Chen, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Prevention of recurrent hepatitis B after liver transplantation- Chung Mau Lo, BBS, JP, MBBS, MS, FRCS, FRACS, FACS, FHKAM (Surgery), FCSHK
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Elimination of viral hepatitis: Global perspective- Zhongdan Chen, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Treatment of CHB in China: Experience and evidence from real-world studies- Jidong Jia, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Non-viral liver diseases in China- Zhongping Duan, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
CHB treatment with Chinese medicine and NAs- Yongping Yang, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
CHB treatment with Chinese medicine and NAs- Yongping Yang, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Efficacy and tolerability of grazoprevir and elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV and HIV co-infection: A nonrandomised, open-label clinical trial- Chien-Yu Cheng
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
HIV-1/HCV co-infection treatment with single-tablet antiviral regimens (CoSTARs): 12 Weeks of Ledipasvir/ Sofosbuvir (LDV/SOF) after randomized switch to Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir alafenamide (E/C/F/TAF) or rilpivirin- Damian Mccoll
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
New indicators for the evaluation of hepatitis B therapy- Xinxin Zhang, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Sequential cross-section study on hepatitis viruses infection in Chinese AIDS patients- Lin Liu, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Non-alcoholic fatty liver disease in China- Jiangao Fan, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
(perinatal) Hepatitis B - Mother to Child transmission - Po-Lin Chan
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
A Model for Collaborative Care to Increase Testing and Treatment of HCV in a Shelter Population Dur - Nicola Gale
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
Achieving Health Equity Through Hepatitis Elimination - John Ward
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
Challenge and Opportunity for HCV Elimination among Young PWID in New York City Relativel - Pedro Mateu-Gelabert
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
Can We Eliminate Viral Hepatitis Among Migrant Populations in Europe - Jeffrey Lazarus
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
Cost-effective testing Hepatitis C - Diagnostic tool (FIND) - Jag Chhatwal
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
Cost-effectiveness modelling of expanding DAA treatment for Hepatitis C among HIV + MSM in Thailand - Shreoshee Mukherjee
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020